Fake medicine sales on Internet increase

9 April 2006

The European Commission has warned consumers about an obesity drug currently sold on the Internet which has not passed the safety evaluation process of the European Medicines Agency (EMEA). A recent survey identified 170 medicines found in counterfeit distribution channels, mainly on the Internet, in 2000-2005. The most popular illicit products identified include lifestyle drugs, growth hormones for body-building use and sleeping pills. Illegal copies of licensed medicines such Viagra (sildenafil) or Tamiflu (oseltamivir) have also been sold.

The Commission is particularly concerned about French drugmaker Sanofi-Aventis' Acomplia (rimonabant), which is currently under evaluation by the EMEA.

Commissioner Gunter Verheugen, responsible for enter-prise and industry, said he is "alarmed at the ever increas-ing number of counterfeit medicines sold via the Internet. This represents a real danger to the health of patients."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight